While BRAFV600E-inhibition has been previously shown to increase tumor infiltrating lymphocytes, it has also been shown to induce the expression of T cell exhaustion markers including PD-L1, TIM3 and PD1 in melanoma patients [53]. The gene discussed is HAVCR2; the disease is neoplasm.